MRNA

Moderna
D

MRNA

38.890
USD
3.00
(8.36%)
مفتوح الان
حجم التداول
743,763
الربح لكل سهم
-9
العائد الربحي
-
P/E
-7
حجم السوق
14,973,261,026
التوصيات
    Abdilatif
    Abdilatif
    منذ 11 شهر
    sell
    MRNA
    MRNA@101.02
    2024-02-01 09:45
    MRNA@101.02 Chart
    الربح
    357.00
    Abdilatif
    Abdilatif
    منذ 11 شهر
    sell
    MRNA
    MRNA@101.83
    2024-01-29 10:09
    MRNA@101.83 Chart
    الربح
    -175.00
    المزيد
الأفكار والتحليلات
    هشام منسي
    هشام منسي
    منذ 3 أشهر
    neutral
    2024-10-01 09:30
    MRNA Chart
    المزيد
أصول ذات صلة
    ABBV
    ABBV
    -1.960
    (-1.14%)
    170.325 USD
    AZN
    AZN
    0.240
    (0.35%)
    68.195 USD
    BMY
    BMY
    0.060
    (0.11%)
    57.110 USD
    BNTX
    BNTX
    -1.980
    (-1.69%)
    115.360 USD
    GSK
    GSK
    -0.250
    (-0.74%)
    33.530 USD
    JNJ
    JNJ
    -3.805
    (-2.57%)
    144.400 USD
    MRK
    MRK
    -0.250
    (-0.26%)
    95.950 USD
    N
    NVAX
    -0.04000
    (-0.45%)
    8.78000 USD
    PFE
    PFE
    -0.416
    (-1.56%)
    26.190 USD
    REGN
    REGN
    -1.77
    (-0.26%)
    685.55 USD
    المزيد
الأخبار المقالات

العنوان: Moderna

القطاع: Healthcare
الصناعة: Biotechnology
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.